Shu Su

999 total citations
45 papers, 701 citations indexed

About

Shu Su is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Shu Su has authored 45 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 15 papers in Infectious Diseases and 9 papers in Hepatology. Recurrent topics in Shu Su's work include HIV, Drug Use, Sexual Risk (15 papers), HIV/AIDS Research and Interventions (13 papers) and Sex work and related issues (8 papers). Shu Su is often cited by papers focused on HIV, Drug Use, Sexual Risk (15 papers), HIV/AIDS Research and Interventions (13 papers) and Sex work and related issues (8 papers). Shu Su collaborates with scholars based in China, Australia and United States. Shu Su's co-authors include Lei Zhang, Christopher K. Fairley, Peng Peng, Jun Jing, Shengyang Jiang, Minjie Chu, Xun Zhuang, Feng Cheng, Jason J. Ong and Kathryn E. Muessig and has published in prestigious journals such as Renewable and Sustainable Energy Reviews, Scientific Reports and International Journal of Environmental Research and Public Health.

In The Last Decade

Shu Su

41 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Su China 14 452 247 150 101 69 45 701
Mukta Sharma United States 18 395 0.9× 361 1.5× 115 0.8× 58 0.6× 66 1.0× 83 1.0k
Peizhen Zhao China 15 285 0.6× 176 0.7× 102 0.7× 30 0.3× 65 0.9× 68 622
Lillian Lourenço Canada 14 411 0.9× 479 1.9× 97 0.6× 93 0.9× 27 0.4× 21 722
Jane Falconer United Kingdom 14 321 0.7× 226 0.9× 44 0.3× 175 1.7× 192 2.8× 52 915
Jesús Troya Spain 14 302 0.7× 445 1.8× 45 0.3× 158 1.6× 32 0.5× 50 741
Bharat Bhushan Rewari India 16 323 0.7× 340 1.4× 71 0.5× 117 1.2× 83 1.2× 37 619
Wendy Carter Canada 13 192 0.4× 109 0.4× 86 0.6× 138 1.4× 104 1.5× 25 659
Marc A. Pitasi United States 13 777 1.7× 382 1.5× 104 0.7× 568 5.6× 25 0.4× 20 1.1k
Hamish McManus Australia 15 378 0.8× 351 1.4× 99 0.7× 96 1.0× 15 0.2× 58 706
Sahar Saeed Canada 19 569 1.3× 346 1.4× 48 0.3× 491 4.9× 212 3.1× 62 1.4k

Countries citing papers authored by Shu Su

Since Specialization
Citations

This map shows the geographic impact of Shu Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Su more than expected).

Fields of papers citing papers by Shu Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Su. The network helps show where Shu Su may publish in the future.

Co-authorship network of co-authors of Shu Su

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Su. A scholar is included among the top collaborators of Shu Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Su. Shu Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yangping, et al.. (2025). Evolving multimorbidity patterns among ageing adults with cardiovascular disease continuum in Southwest China: A longitudinal cohort study. International Journal of Cardiology Cardiovascular Risk and Prevention. 25. 200417–200417. 1 indexed citations
3.
Mao, Jinning, et al.. (2025). Analysis of multimorbidity patterns in perimenopausal women based on medical examination data. Climacteric. 28(4). 456–463.
4.
Su, Shu, et al.. (2024). Exploration of the Healthy Donor Effect Among 0.6 Million Blood Donors in China: Longitudinal Study. JMIR Public Health and Surveillance. 10. e48617–e48617. 3 indexed citations
6.
Li, Rui, Mingwang Shen, Jason J. Ong, et al.. (2023). Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies. JHEP Reports. 5(10). 100833–100833. 9 indexed citations
7.
Bao, Yining, Xueli Zhang, Shu Su, et al.. (2023). Exploring multimorbidity profiles in middle-aged inpatients: a network-based comparative study of China and the United Kingdom. BMC Medicine. 21(1). 495–495. 11 indexed citations
10.
Li, Shifu, et al.. (2020). Syphilis seroprevalence and seroconversion among people newly diagnosed with HIV during the pre-antiretroviral therapy period in rural China. International Journal of STD & AIDS. 31(9). 876–885. 4 indexed citations
11.
Su, Shu, Christopher K. Fairley, Limin Mao, et al.. (2019). Estimates of the national trend of drugs use during 2000–2030 in China: A population-based mathematical model. Addictive Behaviors. 93. 65–71. 15 indexed citations
12.
Zhao, Jing, Zhanwen Zhang, Shu Su, et al.. (2019). PET Imaging of Hepatocellular Carcinomas: 18F-Fluoropropionic Acid as a Complementary Radiotracer for 18F-Fluorodeoxyglucose. Molecular Imaging. 18. 11 indexed citations
13.
Ma, Xiaomeng, Qian Wang, Jason J. Ong, et al.. (2018). Prevalence of human papillomavirus by geographical regions, sexual orientation and HIV status in China: a systematic review and meta-analysis. Sexually Transmitted Infections. 94(6). 434–442. 53 indexed citations
14.
Su, Shu, Limin Mao, Chen Liang, et al.. (2018). Epidemics of HIV, HCV and syphilis infection among synthetic drugs only users, heroin-only users and poly-drug users in Southwest China. Scientific Reports. 8(1). 6615–6615. 13 indexed citations
15.
Su, Shu, Lei Zhang, Feng Cheng, et al.. (2018). Association between recreational drug use and sexual practices among people who inject drugs in Southwest China: a cross-sectional study. BMJ Open. 8(6). e019730–e019730. 7 indexed citations
17.
Su, Shu, Christopher K. Fairley, Joe Sasadeusz, et al.. (2017). HBV, HCV, and HBV/HCV co‐infection among HIV‐positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome. Journal of Medical Virology. 90(3). 518–525. 11 indexed citations
18.
Peng, Peng, Shu Su, Christopher K. Fairley, et al.. (2017). A Global Estimate of the Acceptability of Pre-exposure Prophylaxis for HIV Among Men Who have Sex with Men: A Systematic Review and Meta-analysis. AIDS and Behavior. 22(4). 1063–1074. 146 indexed citations
19.
Su, Shu, Shifu Li, Shunxiang Li, et al.. (2016). Gaps in the Continuum of HIV Care: Long Pretreatment Waiting Time between HIV Diagnosis and Antiretroviral Therapy Initiation Leads to Poor Treatment Adherence and Outcomes. BioMed Research International. 2016. 1–8. 12 indexed citations
20.
Su, Shu, Xi Chen, Limin Mao, et al.. (2016). Superior Effects of Antiretroviral Treatment among Men Who have Sex with Men Compared to Other HIV At-Risk Populations in a Large Cohort Study in Hunan, China. International Journal of Environmental Research and Public Health. 13(3). 283–283. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026